Dynamic Contrast-Enhanced Perfusion Processing for Neuroradiologists: Model-Dependent Analysis May Not Be Necessary for Determining Recurrent High-Grade Glioma versus Treatment Effect

被引:17
作者
Hamilton, J. D. [1 ,4 ]
Lin, J. [2 ,5 ,6 ]
Ison, C. [1 ]
Leeds, N. E. [1 ]
Jackson, E. F. [2 ]
Fuller, G. N. [3 ]
Ketonen, L. [1 ]
Kumar, A. J. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Sect Neuroimaging, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Sect MRI Phys, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Sect Neuropathol, Houston, TX 77030 USA
[4] Radiol Partners Houston, Houston, TX 77040 USA
[5] Rice Univ, Houston, TX USA
[6] Baylor Coll Med, Houston, TX 77030 USA
关键词
CEREBRAL BLOOD-VOLUME; RADIATION-INJURY; INDUCED NECROSIS; BRAIN; LEAKAGE; TRIALS;
D O I
10.3174/ajnr.A4190
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Dynamic contrast-enhanced perfusion MR imaging has proved useful in determining whether a contrast-enhancing lesion is secondary to recurrent glial tumor or is treatment-related. In this article, we explore the best method for dynamic contrast-enhanced data analysis. MATERIALS AND METHODS: We retrospectively reviewed 24 patients who met the following conditions: 1) had at least an initial treatment of a glioma, 2) underwent a half-dose contrast agent (0.05-mmol/kg) diagnostic-quality dynamic contrast-enhanced perfusion study for an enhancing lesion, and 3) had a diagnosis by pathology within 30 days of imaging. The dynamic contrast-enhanced data were processed by using model-dependent analysis (nordicICE) using a 2-compartment model and model-independent signal intensity with time. Multiple methods of determining the vascular input function and numerous perfusion parameters were tested in comparison with a pathologic diagnosis. RESULTS: The best accuracy (88%) with good correlation compared with pathology (P = .005) was obtained by using a novel, model-independent signal-intensity measurement derived from a brief integration beginning after the initial washout and by using the vascular input function from the superior sagittal sinus for normalization. Modeled parameters, such as mean endothelial transfer constant > 0.05 minutes(-1), correlated (P = .002) but did not reach a diagnostic accuracy equivalent to the model-independent parameter. CONCLUSIONS: A novel model-independent dynamic contrast-enhanced analysis method showed diagnostic equivalency to more complex model-dependent methods. Having a brief integration after the first pass of contrast may diminish the effects of partial volume macroscopic vessels and slow progressive enhancement characteristic of necrosis. The simple modeling is technique- and observer-dependent but is less time-consuming.
引用
收藏
页码:686 / 693
页数:8
相关论文
共 21 条
  • [1] The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
    Ballman, Karla V.
    Buckner, Jan C.
    Brown, Paul D.
    Giannini, Caterina
    Flynn, Patrick J.
    LaPlant, Betsy R.
    Jaeckle, Kurt A.
    [J]. NEURO-ONCOLOGY, 2007, 9 (01) : 29 - 38
  • [2] Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
    Barajas, Ramon F., Jr.
    Chang, Jamie S.
    Segal, Mark R.
    Parsa, Andrew T.
    McDermott, Michael W.
    Berger, Mitchel S.
    Cha, Soonmee
    [J]. RADIOLOGY, 2009, 253 (02) : 486 - 496
  • [3] Distinguishing Recurrent High-grade Gliomas from Radiation Injury: A Pilot Study Using Dynamic Contrast-enhanced MR Imaging
    Bisdas, Sotirios
    Naegele, Thomas
    Ritz, Rainer
    Dimostheni, Artemisia
    Pfannenberg, Christina
    Reimold, Matthias
    Koh, Tong San
    Ernemann, Ulrike
    [J]. ACADEMIC RADIOLOGY, 2011, 18 (05) : 575 - 583
  • [4] T1- and T2*-dominant extravasation correction in DSC-MRI: Part I-theoretical considerations and implications for assessment of tumor hemodynamic properties
    Bjornerud, Atle
    Sorensen, A. Gregory
    Mouridsen, Kim
    Emblem, Kyrre E.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (10) : 2041 - 2053
  • [5] Effect of bevacizumab on radiation necrosis of the brain
    Gonzalez, Javier
    Kumar, Ashok J.
    Conrad, Charles A.
    Levin, Victor A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (02): : 323 - 326
  • [6] Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
    Hu, L. S.
    Baxter, L. C.
    Smith, K. A.
    Feuerstein, B. G.
    Karis, J. P.
    Eschlbacher, J. M.
    Coons, S. W.
    Nakaji, P.
    Yeh, R. F.
    Debbins, J.
    Heiserman, J. E.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (03) : 552 - 558
  • [7] Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging
    Jackson, Alan
    O'Connor, James P. B.
    Parker, Geoff J. M.
    Jayson, Gordon C.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3449 - 3459
  • [8] Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy
    Kohshi, K
    Imada, H
    Nomoto, S
    Yamaguchi, R
    Abe, H
    Yamamoto, H
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 209 (1-2) : 115 - 117
  • [9] Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
    Kumar, AJ
    Leeds, NE
    Fuller, GN
    Van Tassel, P
    Maor, MH
    Sawaya, RE
    Levin, VA
    [J]. RADIOLOGY, 2000, 217 (02) : 377 - 384
  • [10] The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
    Leach, MO
    Brindle, KM
    Evelhoch, JL
    Griffiths, JR
    Horsman, MR
    Jackson, A
    Jayson, GC
    Judson, IR
    Knopp, MV
    Maxwell, RJ
    McIntyre, D
    Padhani, AR
    Price, P
    Rathbone, R
    Rustin, GJ
    Tofts, PS
    Tozer, GM
    Vennart, W
    Waterton, JC
    Williams, SR
    Workmanw, P
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (09) : 1599 - 1610